MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-MH-20-0002430
Cognition Pharmaceuticals Private Limited
Cognition Pharmaceuticals Private Limited - chemicals in Yavatmal, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.79 Lakh
▲ 4% YoY
Net profit · FY 2025
₹23,609
Net margin 6.2%
EBITDA · FY 2025
₹33,407
EBITDA margin 8.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Cognition Pharmaceuticals Private Limited
Data last updated:
Cognition Pharmaceuticals Private Limited is a private limited company based in Yavatmal, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 10 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24230MH2019PTC334215. Its GSTIN is 27AAICC5165B1ZU (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mangesh Madan Mudgal and Madan Nathuprasad Mudgal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No 68 Darda Nagar, Yavatmal, Maharashtra, India – 445001.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.79 Lakh, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹23,609 (net margin 6.2%) and EBITDA of ₹33,407 (EBITDA margin 8.8%). Revenue has grown at a compounded annual rate (CAGR) of 26% over three years.
Cognition Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0002430).
Company details
CIN U24230MH2019PTC334215
Registration Number 334215
Incorporation Date 10 December 2019
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-20-0002430
Recognitions & Rankings of Cognition Pharmaceuticals
Contact details
Cognition Pharmaceuticals Private Limited's registered office is in Yavatmal, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No 68 Darda Nagar, Yavatmal, Maharashtra, India – 445001
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Cognition Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Cognition Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Cognition Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Cognition Pharmaceuticals Private Limited, buy the company report.
Financials of Cognition Pharmaceuticals Private Limited
FY 2025 filings availableCognition Pharmaceuticals Private Limited reported revenue of ₹3.79 Lakh (up 4% YoY) for FY 2025.
Revenue · FY 2025
₹3.79 Lakh ▲ 4%
Net profit · FY 2025
₹23,609 margin 6.2%
EBITDA · FY 2025
₹33,407 margin 8.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▲ 26%
EBITDA CAGR growth
3 years · compounded
▲ 28%
5 years · compounded
▲ 20%
Revenue has grown at a compounded annual rate (CAGR) of 26% over three years, including 4% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹33,407 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹23,609 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.8% | ||||
| Net Profit Margin | 6.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cognition Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cognition Pharmaceuticals Private Limited
Cognition Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mangesh Madan Mudgal Also directs: Cognition Pharma Global Private Limited | Director | 10 Dec 2019 | 6 Years 10 Months | Current |
| Madan Nathuprasad Mudgal Also directs: Cognition Pharma Global Private Limited | Director | 10 Dec 2019 | 6 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Cognition Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cognition Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cognition Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICC5165B1ZU | Maharashtra | Active | 08 Feb 2021 |
To see the full GST registrations and return filing status of Cognition Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cognition Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Madan Nathuprasad Mudgal was appointed as Director on 10 Dec 2019.
AGM
Cognition Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cognition Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur.
Appointed
Madan Nathuprasad Mudgal was appointed as Director.
Appointed
Mangesh Madan Mudgal was appointed as Director.
Incorporation
10 Dec 2019
Cognition Pharmaceuticals Private Limited was registered on 10 Dec 2019 with Roc Nagpur & aged 6 years 10 months as per MCA records.
Frequently asked questions
Cognition Pharmaceuticals is an active private limited company based in Yavatmal, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 10 December 2019 (7+ years old) and is registered under CIN U24230MH2019PTC334215.
Cognition Pharmaceuticals has 2 current directors:
- Mangesh Madan Mudgal - Director
- Madan Nathuprasad Mudgal - Director
The latest financial statements of Cognition Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Cognition Pharmaceuticals is 27AAICC5165B1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Cognition Pharmaceuticals is U24230MH2019PTC334215. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cognition Pharmaceuticals was incorporated on 10 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Nagpur.
Madan Nathuprasad Mudgal was appointed as Director on 10 Dec 2019. Mangesh Madan Mudgal was appointed as Director on 10 Dec 2019.
Yes, Cognition Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0002430).
The registered office of Cognition Pharmaceuticals is at Plot No 68 Darda Nagar, Yavatmal, Maharashtra, India – 445001.
Cognition Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.